See Trial IntelX in Action at Booth #20
SCOPE X is a new, technology‑focused conference built for teams navigating tighter timelines, rising protocol complexity, and increasing pressure to make the right decisions earlier. WCG will be onsite in Boston showcasing ClinSphere® Trial IntelX, our unified trial intelligence solution designed to bring foresight to trial planning.
If protocol changes, enrollment delays, and late‑stage surprises are familiar challenges, Trial IntelX offers a different way forward — one grounded in real‑world data, not assumptions.
Turn trial complexity into clarity — before it becomes risk.
As trials grow more complex, small design choices can create outsized downstream impact. Trial IntelX connects protocol design, operational performance, and historical outcomes to help teams identify risk early — before timelines slip or amendments become unavoidable.
Built on insights from 80,000+ complete digitized protocols and 40,000+ operationally benchmarked trials, Trial IntelX enables teams to:
- Surface enrollment and timeline risk before protocol lock.
- Quantify participant and site burden during study design.
- Compare country and site options using real performance data.
- Pressure‑test design assumptions with scenario modeling.
- Reduce costly amendments by addressing risk upfront.
See It in Action at SCOPE X
Meet with the WCG team at Booth #20 to see how Trial IntelX supports smarter trial planning and helps teams anticipate challenges, align decisions earlier, and move forward with confidence.